Page 73 - Read Online
P. 73

Page 8 of 16                                Chávez-López et al. Hepatoma Res 2020;6:14  I  http://dx.doi.org/10.20517/2394-5079.2019.023

               function studies showed that KCNQ1 exhibited remarkable inhibitory roles on tumor metastasis in vitro
               and in vivo; thus, this channel could represent a prognostic marker, as well as a promising therapeutic
               target for HCC [105] . Another study found that the KCNJ11 channel was differentially expressed in HCC,
               and it predicted the poor prognosis in HCC patients. KCNJ11 promotes tumor progression through
               interaction with lactate dehydrogenase A (LDHA). Pharmacological inhibition of LDHA or knockdown of
               KCNJ11 expression inhibited cell proliferation, promoted apoptosis, and reduced cell invasive capacity [106] .
               K  channels regulate mitogen-induced proliferation in the human liver cell lines HepG2, which could
                 ATP
                                                                                        [37]
               have implications for liver growth control and serve as a potential therapeutic target . The voltage-gated
               potassium channel ether à-go-go-1 (Eag1) has gained enormous interest in cancer research because of
               its oncogenic properties [107-109] . Eag1 channels have also been proposed as early tumor biomarkers and
               therapeutic targets for different types of cancers [110,111] . Moreover, the inhibition of Eag1 reduces tumor
               cell proliferation in vitro and in vivo [112-114] . We reported that HepG2 and HuH-7 HCC cells displayed Eag1
               channel expression, and that the anti-histamine astemizole (a non-specific Eag1 inhibitor) decreased cell
               proliferation and induced apoptosis in both cell lines. In addition, an increase in Eag1 expression was
               found during HCC development in rats. Astemizole treatment prevented HCC development and seems to
               induce tumor regression in rats with HCC [115] .

               T-type calcium channels play an important role in cell cycle progression in different types of cancer [116] .
               The expression of the three T-type calcium channel subunits was observed in HCC cell lines and T-type
               channel blockage with mibefradil decreased cell proliferation in the SNU449 cell line [117] . P2 purinergic
               receptors are overexpressed in certain cancer tissues; the levels of P2Y2 receptor are enhanced in HCC
                                                                                                2+
               compared with human normal hepatocytes. These receptors are involved in ATP-induced (Ca ) increase.
                                                                                                  i
               Silencing P2Y2R expression inhibited ATP-induced human HCC cell proliferation and migration, and
               P2Y2R blockage inhibited cell growth in mice [21,118] . In addition, high P2X3 receptor expression is associated
               with poor recurrence-free survival in HCC, while high P2Y13 expression is associated with improved
               recurrence-free survival. Moreover, extracellular nucleotide treatment induce cell cycle progression and
               extracellular ATP-mediated activation of P2X3 receptors promotes proliferation of HCC cells [119] . SOCE
                           2+
                                                                     2+
               is a major Ca  influx pathway controlling the intracellular Ca  concentration in normal hepatocytes and
                                2+
               HCC cells, and Ca  influx has been demonstrated to be involved in liver oncogenesis. Accordingly, the
               blockade of SOCE inhibits hepatocarcinoma cell migration and invasion, by regulating focal adhesion
               turnover [120] . The activation of SOCE channels is implicated in cancer cell chemoresistance, although the
                                                                                                         2+
               underlying molecular mechanisms are not well understood. However, inhibition of Orai1-mediated Ca
               entry enhances chemosensitivity to 5-fluorouracil of HepG2 hepatocarcinoma cells [121] . The specific roles
               and molecular mechanisms of calcium entry in drug response deserve further investigation.


               CIC-3 chloride channels have multiple functions in tumorigenesis and tumor growth in HCC; the CIC-3
               channel blocker DIDS (4,4’-diisothiocyanostilbene-2,2’-disulfonic acid) arrests the cell at the G1 phase,
               inhibiting the proliferation of Hep3B HCC cells [122] . Proteomic approaches found that the chloride
               intracellular channel 1 (CLIC1) is upregulated in HCC tissues, and that it participates in HCC migration
               and invasion by targeting maspin [123] .


               The voltage-gated sodium channel β1 subunit was proposed as a cell adhesion molecule in some HCC
               cell lines. The analgesic-antitumor peptide (a scorpion toxin polypeptide with antitumor activity) inhibits
               the migration and invasion of HepG2 cells by an upregulated VGSC β1 subunit [124] . Additionally the over-
                                                                             [96]
               expression of Nav  channels has been observed in an HCC in vivo model .
                              1.2
               AQP5 is highly expressed in HCC cell lines and its downregulation inhibits HCC cell invasion and tumor
               metastasis. Downregulation of AQP5 suppressed the epithelial-to-mesenchymal transition process in HCC
               cells [125] . Another report found that microRNA-325-3p inhibits cell proliferation and induces apoptosis
   68   69   70   71   72   73   74   75   76   77   78